Efficacy and safety of budesonide /formeterol inhalation in asthma patients with high fractional exhaled NO.
Not Applicable
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000003735
- Lead Sponsor
- Komaki City Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) have hypersensitivity with budesonide 2) have any severe complications 3) use of oral corticosteroids or systemic rescue medication 4) physician decided the patient is unsuitable for enrollment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary function levels at 0, 4, 12 weeks. Fractional exhaled nitric oxide levels at 0, 4, 12 weeks. Values of impulse oscillometry at 0, 4, 12 weeks Adverse events
- Secondary Outcome Measures
Name Time Method Exacerbations during 12weeks